Theorizing why tirzepatide could be more practical for weight loss than Ozempic, Tchang describes that Tirzepatide can be a dual GLP-1/GIP receptor agonist. This implies it improves the activity of gut peptides that promote satiety, even though GIP also stimulates lipolysis – the breakdown of